Shanghai Kaibao Pharmaceutical Co.,Ltd.’s Net Profit Rose 35.7% in 2022

Shanghai Kaibao Pharmaceutical Co.,Ltd. (上海凯宝药业股份有限公司) (300039.SZ) reported a net profit of 190.1 million yuan in 2022, up 35.7% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, up 1.7% year-on-year.

At the end of the reporting period, it had 4.3 billion yuan in total assets and 498.2 million yuan in total liabilities, with a liability-to-asset ratio of 11.7%.